conjunctivitis

fast speed night U-turn drive overpass
Biotech

With FDA rejection for eye drug, Aldeyra plans speedy new trial

Aldeyra Therapeutics had prepared for the worst and now it's here. The FDA has rejected the dry eye drug reproxalap.
Annalee Armstrong Nov 28, 2023 4:30am
eye eyeball retinal diseases

Aldeyra's dry eye disease drug scores phase 3 conjunctivitis win

Jun 15, 2023 9:30am
FDA

Eton Pharma dips as FDA rejects its conjunctivitis med

Jul 15, 2019 9:52am
allergic conjunctivitis

Realm scraps eye drug after midphase flop, sinking stock

Mar 12, 2018 9:00am
handshake

Anti-inflammatory biotech Aldeyra teams up with Janssen

Feb 27, 2018 9:58am
Spotlight

Tiny Aldeyra’s eye drug misses primary endpoint in phase 2

Jun 14, 2017 7:45am